AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35
USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W KROSCHKE G ZELLER W HOFFKNECHT M LOLIGER C KABISCH H ZANDER A
Citation: M. Stockschlader et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 569-572
EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER W STOCKSCHLADER M RUSSMANN B BERGER C HOFFKNECHT M SOBOTTKA I KOHLSCHUTTER B KROSCHKE G KROGER N HORSTMANN M KABISCH H ZANDER AR
Citation: W. Kruger et al., EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, British Journal of Haematology, 91(3), 1995, pp. 684-690
CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA TRANSPLANTED WITH BONE-MARROW FROM HLA-IDENTICAL RELATED DONORS/
Authors: HORSTMANN M STOCKSCHLADER M KABISCH H ZANDER A
Citation: M. Horstmann et al., CYCLOPHOSPHAMIDE ANTITHYMOCYTE GLOBULIN CONDITIONING OF PATIENTS WITHSEVERE APLASTIC-ANEMIA TRANSPLANTED WITH BONE-MARROW FROM HLA-IDENTICAL RELATED DONORS/, Blood, 85(5), 1995, pp. 1404-1405
REDUCTION OF RADIATION DOSAGE TO 20-30 GY IN THE FRAMEWORK OF A COMBINED CHEMORADIOTHERAPY IN CHILDHOOD HODGKINS-DISEASE - A REPORT OF THE COOPERATIVE THERAPY STUDY DAL-HD-87
Authors: SCHELLONG G HORNIGFRANZ I RATH B RITTER J RIEPENHAUSEN M KABISCH H GOLDSCHMITTWUTTGE B SCHMIDT P NIETHAMMER D GAEDICKE G SCHWARZE EW POTTER R WANNENMACHER M
Citation: G. Schellong et al., REDUCTION OF RADIATION DOSAGE TO 20-30 GY IN THE FRAMEWORK OF A COMBINED CHEMORADIOTHERAPY IN CHILDHOOD HODGKINS-DISEASE - A REPORT OF THE COOPERATIVE THERAPY STUDY DAL-HD-87, Klinische Padiatrie, 206(4), 1994, pp. 253-262
SCREENING FOR NEUROBLASTOMA
Authors: SCHILLING FH ERTTMANN R AMBROS PF STREHL S CHRISTIANSEN H KOVAR H KABISCH H TREUNER J
Citation: Fh. Schilling et al., SCREENING FOR NEUROBLASTOMA, Lancet, 344(8930), 1994, pp. 1157-1158
HIGHER DOSE OF G-CSF INCREASES YIELD OF MOBILIZED CD34+ CELLS
Authors: ZELLER W CASSENS U STOCKSCHLADER M KRUGER W KABISCH H KUHNL P HOSSFELD DK ZANDER AR
Citation: W. Zeller et al., HIGHER DOSE OF G-CSF INCREASES YIELD OF MOBILIZED CD34+ CELLS, Blood, 84(10), 1994, pp. 10000106-10000106
EFFECT OF CRYOPRESERVED DONOR BONE-MARROW ON ENGRAFTMENT AND GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: STOCKSCHLADER M KRUGER W ZELLER W KROSCHKE G HOFFKNECHT M KABISCH H ZANDER A
Citation: M. Stockschlader et al., EFFECT OF CRYOPRESERVED DONOR BONE-MARROW ON ENGRAFTMENT AND GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000722-10000722
RAPID SCREENING FOR TP53 MUTATIONS BY TEMPERATURE-GRADIENT GEL-ELECTROPHORESIS - A COMPARISON WITH SSCP ANALYSIS
Authors: SCHOLZ RB MILDELANGOSCH K JUNG R SCHLECHTE H KABISCH H WAGENER C LONING T
Citation: Rb. Scholz et al., RAPID SCREENING FOR TP53 MUTATIONS BY TEMPERATURE-GRADIENT GEL-ELECTROPHORESIS - A COMPARISON WITH SSCP ANALYSIS, Human molecular genetics, 2(12), 1993, pp. 2155-2158
SYMPTOMATIC PANCREATITIS IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION
Authors: GUTH S STOCKSCHLADER M PETERS S ZELLER W KRUGER W KABISCH H ZANDER AR
Citation: S. Guth et al., SYMPTOMATIC PANCREATITIS IN PATIENTS AFTER BONE-MARROW TRANSPLANTATION, Experimental hematology, 21(8), 1993, pp. 1062-1062
INTRAVENOUS PENTOXIFYLLINE FAILED TO PREVENT TRANSPLANT-RELATED TOXICITIES IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
Authors: STOCKSCHLADER M KALHS P PETERS S ZELLER W KRUGER W KABISCH H LECHNER K ZANDER A
Citation: M. Stockschlader et al., INTRAVENOUS PENTOXIFYLLINE FAILED TO PREVENT TRANSPLANT-RELATED TOXICITIES IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 12(4), 1993, pp. 357-362
Risultati: 1-25 | 26-35 |